Abstract | SCOPE: METHODS AND RESULTS: Male C57BL/6J mice received (i) control diet (10% fat, 20% protein, 70% carbohydrate), (ii) control diet plus n-3 LCPUFAs (daily doses of 108 mg/kg body weight of eicosapentaenoic acid plus 92 mg/kg body weight of docosahexaenoic acid), (iii) HFD (60% fat, 20% protein, 20% carbohydrate), or (iv) HFD plus n-3 LCPUFAs for 12 wk. PPAR-α, tumor necrosis factor alpha (TNF-α), and IL-1β mRNA expression, acyl-CoA oxidase 1 (ACOX1), and carnitine- acyl-CoA transferase 1 (CAT-I) protein contents, and NF-κB DNA binding activity were measured. HFD significantly decreased liver PPAR-α, ACOX1, and CAT-I levels with NF-κB activation, higher TNF-α and IL-1β expression, and steatosis development. These changes were either reduced or normalized to control values in animals subjected to HFD plus n-3 LCPUFAs, with establishment of an inverse association between NF-κB activation and PPAR-α mRNA expression (r = -0.66, p < 0.0001). CONCLUSION: Data presented indicate that n-3 LCPUFAs supplementation prevents liver steatosis and inflammation induced by HFD, with underlying mechanisms involving enhanced PPAR-α signaling and diminished NF-κB activation.
|
Authors | Gladys Tapia, Rodrigo Valenzuela, Alejandra Espinosa, Pamela Romanque, Camila Dossi, Daniel Gonzalez-Mañán, Luis A Videla, Amanda D'Espessailles |
Journal | Molecular nutrition & food research
(Mol Nutr Food Res)
Vol. 58
Issue 6
Pg. 1333-41
(Jun 2014)
ISSN: 1613-4133 [Electronic] Germany |
PMID | 24436018
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Chemical References |
- DNA-Binding Proteins
- Fatty Acids, Omega-3
- Interleukin-1beta
- NF-kappa B
- PPAR alpha
- RNA, Messenger
- Tumor Necrosis Factor-alpha
- Acyl-CoA Oxidase
|
Topics |
- Acyl-CoA Oxidase
(genetics, metabolism)
- Animals
- DNA-Binding Proteins
(genetics, metabolism)
- Diet, High-Fat
(adverse effects)
- Dietary Supplements
- Fatty Acids, Omega-3
(administration & dosage)
- Fatty Liver
(etiology, prevention & control)
- Inflammation
(etiology, prevention & control)
- Interleukin-1beta
(genetics, metabolism)
- Liver
(enzymology)
- Male
- Mice
- Mice, Inbred C57BL
- NF-kappa B
(genetics, metabolism)
- Organ Size
- PPAR alpha
(genetics, metabolism)
- RNA, Messenger
(genetics, metabolism)
- Tumor Necrosis Factor-alpha
(genetics, metabolism)
- Up-Regulation
|